Patent application number | Description | Published |
20150184046 | COMPOSITION, SYSTEM AND METHOD FOR PREVENTING FORMATION OF FROZEN WATER OR FOR CAUSING THE SAME TO MELT - A de/anti-icer composition comprises one or more de/anti-icer moieties and a marker material, the marker material being selected such that, after application of the de/anti-icer composition to a travelled surface, the amount of the marker material at or on the travelled surface at a given time correlates to the amount of said one or more de/anti-icer moieties on the said surface at such time. The presence of the marker material enables the user readily to determine the concentration of the de/anti-icer moiety or the freezing point of liquid on the travelled surface. Methods of using such compositions for concentration and/or freezing point de-termination of de/anti-icer materials applied to travelled surfaces are described, together with systems and kits of parts utilising such compositions. | 07-02-2015 |
20150252239 | De-Icer and/or Anti-Icer Compositions and Methods - The invention relates to a de-icer or anti-icer composition for a travelled surface comprising: at least about 25% w/w of at least one acetate salt; and from about 14% to about 50% w/w of at least one non-acetate salt wherein the total concentration of said at least one acetate salt and said at least one non-acetate salt in the de-icer or anti-icer composition is at least about 57% w/w. The acetate salt can be selected from the group comprising potassium, sodium, lithium, magnesium, calcium, ammonium acetate or mixtures thereof. The non-acetate salt can selected from the group comprising one or more cations selected from the group consisting of potassium, sodium, lithium, magnesium, calcium, ammonium or mixtures thereof and one or more anions selected from the group consisting of formate, propionate, butyrate, isobutyrate, oxalate, malonate, succinate, glutarate, adipate, citrate, gluconate, benzoate, carbonate, bicarbonate, fluoride, chloride, bromide or mixtures thereof. The balance can be solvent and optionally not more than about 5% w/w in total of one or more auxiliary or incidental additives. | 09-10-2015 |
Patent application number | Description | Published |
20120003674 | Chloral Hydrate Detection - The invention relates to an immunoassay method and kit for the indirect detection of chloral hydrate. The invention is underpinned by a novel immunogen that produces an antibody that is specific for the chloral hydrate metabolite trichloroethanol glucuronide. Detection and quantification of trichloroethanol glucuronide has important applications in clinical toxicology, drug facilitated crime, water testing and solvent exposure. | 01-05-2012 |
20130210167 | IMMUNOASSAY FOR PYRROLIDINOPHENONES - The invention describes antibodies that bind molecules of the pyrrolidinophenone class of synthetic drugs. The antibodies are derived from novel chemical intermediates, haptens and immunogens and are used in methods and kits to detect and quantify pyrrolidinophenones. | 08-15-2013 |
20130224878 | BIOCHIP WELL, SEALED WELL ASSEMBLY, CARTRIDGE THEREFOR, AND APPARATUS AND METHODS FOR OPENING SEALED WELLS - A biochip well is disclosed, including a vessel containing a well therewithin, the vessel forming at least base and side walls of the well and defining at least one aperture giving access to the well, and further including retaining means for holding a biochip at a predetermined position within the well, the well including a laterally offset region into which the biochip does not protrude when held at the predetermined position by the retaining means. Also disclosed are sealed well assemblies and apparatus and methods for opening sealed wells. | 08-29-2013 |
20130224882 | Assay for the Detection of the Phenylpiperazine Family - The current invention describes novel immunogens which are used in the production of novel antibodies with unique binding properties in that they cross-react with a variety of phenylpiperazine derivatives. These antibodies enable methods and kits to detect and/or determine phenylpiperazine derivatives (for example mCPP, TFMPP and MeOPP) in an in vitro sample which are advantageous over currently available analytical methods in terms of cost, ease of use, speed and sensitivity. | 08-29-2013 |
20140099651 | IMMUNOASSAYS FOR MEPERIDINE AND METABOLITES - The invention provides novel haptens and immunogens for the preparation of novel monoclonal antibodies, which detect the synthetic opioid meperidine and its active metabolite normeperidine. These antibodies enable methods and kits, which are useful in an immunoassay for therapeutic drug monitoring (TDM) and in extending the window of detection for cases of abuse and drug-facilitated sexual assault (DFSA). | 04-10-2014 |
20140147859 | Venlafaxine Assay - The invention describes antibodies that bind venlafaxine and O-desmethylvenlafaxine. The antibodies are derived from novel haptens and immunogens and are used in methods and kits to detect and quantify venlafaxine and O-desmethylvenlafaxine. The invention also describes novel detecting agents which can be used in the methods and kits of the invention. | 05-29-2014 |
20140242617 | Immunoassay for Detecting Kratom, its Constituents and their Use - The invention relates to the field of drug detection and describes antibody-based components methods and kits for the detection and quantification of alkaloids of the plant kratom. The invention is underpinned by novel antibodies which specifically bind to mitragynine alkaloids found in the kratom plant and their metabolites. | 08-28-2014 |
20140242618 | Ritalinic Acid Immunoassay - The invention provides novel antibodies which specifically bind to the methylphenidate metabolite, ritalinic acid, enabling an immunoassay that can detect methyphenidate in biological samples for an extended period following its ingestion. The invention also describes novel conjugates and kits incorporating the antibodies. | 08-28-2014 |
20140287441 | IMMUNOASSAY FOR CYCLOPROPYLINDOLE BASED SYNTHETIC CANNABINOIDS, METABOLITES AND DERIVATIVES THEREOF - The invention relates to the detection and quantification of cyclopropylindole based synthetic cannabinoids UR-144 and XLR-11 by providing antibodies based on novel immunogens. These antibodies can be incorporated into methods and kits for the detection of UR-144, XLR-11 and their metabolites. | 09-25-2014 |
20150038366 | Immunoassay for Phenethylamines of the 2C and DO Sub-Families - Immunoassay methods and their requisite components for the detection and determination of phenethylamines of the 2C and DO sub-families are described. | 02-05-2015 |
20150185241 | Tilidine Immunodetection - An immunoassay for the detection of tilidine and nortilidine is described. The invention also describes antibodies and kits. | 07-02-2015 |
20150346227 | IMMUNOASSAY FOR SYNTHETIC CANNABINOIDS OF THE ADAMANTYL INDAZOLE/INDOLE-3-CARBOXAMIDE FAMILY - An immunoassay method for detecting and determining adamantane substituted indazole and indole synthetic cannabinoids is described. Also described are components for use in implementing the method, namely, antibodies, detection agents, solid state devices and kits as well as immunogens used to raise the antibodies. | 12-03-2015 |
20160084859 | DETECTION OF INDAZOLE SYNTHETIC CANNABINOIDS - Components for enabling immunodection of indazole synthetic cannabinoids are described including immunogens, haptens, antibodies, methods and kits. | 03-24-2016 |
20160097783 | IMMUNOASSAY FOR PYRROLIDINOPHENONES - The current invention provides an improved immunoassay for the detection and determination of pyrrolidinophenone based designer drugs in hair and biological fluids (urine, blood, and oral fluid). The generic immunoassay is underpinned by novel, sub-family-specific antibodies, which display surprising sensitivity. The invention further describes substrates comprising an antibody that is specific to compounds of the pyrrolidinophenone family. Also described are the novel immunogens from which the antibodies are derived and kits incorporating the antibodies of the current invention. | 04-07-2016 |
20160097784 | DETECTION OF POLYMYXINS - The present invention relates to antibodies for use in detecting polymyxins and tracers; and to a single-capture immunodetection method and kits, each utilising the antibodies of the invention, and disclosed tracers. | 04-07-2016 |
Patent application number | Description | Published |
20130121878 | REAGENT BOTTLES, VALVES THEREFOR, WASHING MODULES AND METHODS AND APPARATUS FOR DISPENSING REAGENTS - A valve for a reagent bottle is provided, the valve including a resilient membrane configured to extend across an opening in the reagent bottle, the resilient membrane having at least one slit extending therethrough. Also disclosed is a dispensing apparatus for dispensing a reagent from a reagent bottle, the dispensing apparatus comprising: a probe assembly having a probe adapted for insertion into the reagent bottle through the valve and an extraction mechanism for drawing reagent out of the reagent bottle through the probe. A valve opening assembly is provided, which is adapted to open the valve of the reagent bottle such that the probe can pass through the valve without contacting the valve. | 05-16-2013 |
20150219670 | KIDNEY DISEASE BIOMARKER - The present invention provides a method of stratifying a patient suffering from CKD into one of stages 1-3 of CKD, comprising determining the level of the biomarkers FABP1, γ-GT, AST, creatinine and cystatin C in a sample obtained from the patient and comparing the level of FABP1 in the sample to a control value and the levels of γ-GT, AST, creatinine and cystatin C in the sample to a range of control values for each biomarker, wherein an increased level of FABP1 compared to the control value and levels of γ-GT, AST, creatinine and cystatin C within the range of control values for each biomarker indicate that the patient suffers from stage 1 CKD or wherein an increased level of FABP1 compared to the control value, levels of γ-GT and AST within the range of control values for each biomarker, and increased levels of creatinine and cystatin C compared to an upper threshold of the control range for these biomarkers indicate that the patient suffers from stage 2 or stage 3 CKD. | 08-06-2015 |
Patent application number | Description | Published |
20120135434 | MCPP IMMUNOASSAY - The invention describes a practical and robust multi-antibody approach to the sensitive immunodetection and determination of the drug of abuse m-chlorophenyl piperazine (mCPP). The invention also describes methods and kits for mCPP detection in an in vitro sample. | 05-31-2012 |
20120164756 | ASPIRIN ASSAY - The invention describes a method for monitoring and detecting non-therapeutic, therapeutic and toxic concentrations of aspirin in individuals which uses the urinary salicylic acid to salicyluric acid ratio. | 06-28-2012 |
20120208213 | Detection of Synthetic Cannabinoids - The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits. | 08-16-2012 |
20130065323 | Detection of Synthetic Cannabinoids - The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the CP family. Unique antibodies derived from novel immunogens enable said methods and kits. | 03-14-2013 |
20130066053 | Detection of Synthetic Cannabinoids - The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits. | 03-14-2013 |
20130196354 | Detection of Synthetic Cannabinoids - The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and RCS families. Unique antibodies derived from novel immunogens enable said methods and kits. | 08-01-2013 |
20150118763 | DETECTION OF SYNTHETIC CANNABINOIDS - The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits. | 04-30-2015 |
Patent application number | Description | Published |
20090164752 | PROCESSOR MEMORY SYSTEM - A data processor comprises a plurality of processing elements (PEs), with memory local to at least one of the processing elements, and a data packet-switched network interconnecting the processing elements and the memory to enable any of the PEs to access the memory. The network consists of nodes arranged linearly or in a grid, e.g., in a SIMD array, so as to connect the PEs and their local memories to a common controller. Transaction-enabled PEs and nodes set flags, which are maintained until the transaction is completed and signal status to the controller e.g., over a series of OR-gates. The processor performs memory accesses on data stored in the memory in response to control signals sent by the controller to the memory. The local memories share the same memory map or space. External memory may also be connected to the “end” nodes interfacing with the network, eg to provide cache. One or more further processors may similarly be connected to the network so that all the PE memories from all the processors share the same memory map or space. The packet-switched network supports multiple concurrent transfers between PEs and memory. Memory accesses include block and/or broadcast read and write operations, in which data can be replicated within the nodes and, according to the operation, written into the shared memory or into the local PE memory. | 06-25-2009 |
20110083000 | DATA PROCESSING ARCHITECTURES FOR PACKET HANDLING - A data processing architecture includes an input device that receives an incoming stream of data packets. A plurality of processing elements are operable to process data received from the input device. The input device is operable to distribute data packets in whole or in part to the processing elements in dependence upon the data processing bandwidth of the processing elements. | 04-07-2011 |
20110107058 | PROCESSOR MEMORY SYSTEM - A plurality of processing elements (PEs) include memory local to at least one of the processing elements in a data packet-switched network interconnecting the processing elements and the memory to enable any of the PEs to access the memory. The network consists of nodes arranged linearly or in a grid to connect the PEs and their local memories to a common controller. The processor performs memory accesses on data stored in the memory in response to control signals sent by the controller to the memory. The local memories share the same memory map or space. The packet-switched network supports multiple concurrent transfers between PEs and memory. Memory accesses include block and/or broadcast read and write operations, in which data can be replicated within the nodes and, according to the operation, written into the shared memory or into the local PE memory. | 05-05-2011 |
20130331954 | DATA PROCESSING UNITS - A data processing unit combines a scalar processor and a heterogeneous processor which includes a vector processing array. The vector processing array includes a plurality of vector processors which are operable in a single instruction multiple data configuration. | 12-12-2013 |
20140040909 | DATA PROCESSING SYSTEMS - A data processing system is described in which a plurality of data processing units | 02-06-2014 |
20150143073 | DATA PROCESSING SYSTEMS - A data processing system is described in which a plurality of data processing units | 05-21-2015 |
20150248353 | PROCESSOR MEMORY SYSTEM - A plurality of processing elements (PEs) include memory local to at least one of the processing elements in a data packet-switched network interconnecting the processing elements and the memory to enable any of the PEs to access the memory. The network consists of nodes arranged linearly or in a grid to connect the PEs and their local memories to a common controller. The processor performs memory accesses on data stored in the memory in response to control signals sent by the controller to the memory. The local memories share the same memory map or space. The packet-switched network supports multiple concurrent transfers between PEs and memory. Memory accesses include block and/or broadcast read and write operations, in which data can be replicated within the nodes and, according to the operation, written into the shared memory or into the local PE memory. | 09-03-2015 |